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Abstract
Background. Intimate partner violence is a highly prevalent problem in the United States and
leads to serious negative physical and psychological health outcomes, including death. There are
screening tools that can detect IPV, yet screening rates in healthcare settings remain low, due to a
variety of barriers, including lack of time, confidence, screening policies, and resources.
Purpose. The purpose of this DNP project was to increase IPV screening rates within a primary
care clinic. Methods. To accomplish the purpose of the project, an education intervention on
IPV and available resources was provided to clinicians and staff. This was followed by
administration of the Extended-Hurt, Insult, Threaten, Scream (E-HITS) screening tool to
women ages 18-55 who presented for an annual physical exam over a 6-week period. Outcomes
included documented screening rates, as well as feedback from clinicians and staff on barriers.
Results. 55 eligible women were seen in the primary care clinic and 44 women completed the EHITS screening, for an 80% screening rate. Three clinicians (n=3, 50%) and four nursing staff
members (n=4, 66.67%) responded to the survey and 100% of participants somewhat or strongly
agreed that the screening was efficient. 100% of clinicians felt very or extremely confident in
responding to IPV. Almost all (n=3, 75%) nursing staff members denied barriers to screening.
Conclusion. IPV is a highly prevalent and can lead to dangerous health outcomes. Primary care
clinicians and nursing staff are in a unique position to screen and provide interventions and
resources for patients experiencing IPV. Screening can be efficient in the primary care setting,
and policies should be in place to help support clinicians and nursing staff members to
consistently screen eligible patients.
Keywords: Intimate partner violence, IPV, screening, primary care
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Implementing Intimate Partner Violence Screening into the Primary Care Setting
Intimate partner violence (IPV) is defined as sexual, physical, and/or psychological abuse
by an intimate partner that 36% of women in the United States experience during their lifetime
(United States Preventative Services Task Force [USPSTF], 2018). This highly prevalent
problem leads to negative health outcomes and has been found to be accurately detected by
screening tools. However, the rates of screening among primary care clinicians remains low.
Background
IPV affects all genders, ages, races, ethnicities, and socioeconomic statuses, however,
there are certain factors that place people at increased risk of experiencing IPV (Weil, 2020b).
Risk factors for IPV include prior history of IPV, female gender, age under 24, unemployment or
low educational background, witnessing IPV as a child, and African American and Alaskan
Native race (Weil, 2020b). Relationship factors also can put someone at risk for IPV, including
high levels of jealousy or controlling behavior from a male partner (Weil, 2020b). Community
factors that increase IPV risk include isolation during the Covid-19 pandemic, gender norms that
reinforce notions that women should be submissive to men, and lack of community punishment
against those who perpetrate IPV (Weil, 2020b).
Women who experience IPV are at higher risk of poor physical and mental health
outcomes. Some negative physical health outcomes that have been associated with IPV include
musculoskeletal pain, headaches, gynecologic disorders and genitourinary infections such as
sexually transmitted infections or urinary tract infections (Weil, 2020b). Negative mental health
outcomes that can result from IPV include post-traumatic stress disorder, eating disorders, sleep
disorders, psychosocial challenges, and suicide attempts (Weil, 2020b). IPV can also result in
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suicide or homicide (Weil, 2020b). 14% of homicides in 2007 were attributed to IPV (Weil,
2020b).
Healthcare providers are in a unique position to screen for IPV and have been
recommended to do so by a variety of professional organizations, including the USPSTF, the
American Academy of Family Physicians, the American College of Obstetricians and
Gynecologists, and the American Academy of Pediatrics (USPSTF, 2018). There have been
screening tools identified that accurately detect IPV in women of a reproductive age (USPSTF,
2018). Although it is known that individuals of all genders and ages experience IPV, there have
not been screening tools identified that can accurately detect IPV in groups other than women of
a reproductive age, so it has not been recommended to screen these groups (USPSTF, 2018).
Problem Statement
The risk of IPV among women of a reproductive age is indicated by high rates (1 in 3
women in the United States) of psychological, physical, and sexual abuse that can result in a
range of negative health outcomes and is in part a result of lack of screening and identification of
IPV in healthcare settings where opportunity for intervention exists.
Organizational “Gap” Analysis of Project Site
Gap analyses are important tools to help bridge the gap between evidence and clinical
practice, which can help improve safety and quality outcomes in healthcare (Davis-Ajami et al.,
2014). Using practice guidelines as the best evidence and comparing that with what is typically
being done in a practice setting sets the foundation for the gap analysis (Davis-Ajami et al.,
2014) and therefore for the entire capstone project for the DNP student. This gap analysis will
present the best practice for IPV screening and compare that with the current practice in an
identified primary care setting.
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The PRECEDE/PROCEED model was used to conduct the gap analysis. This model
ensures engagement with the community where the project is taking place (The University of
Kansas [KU], 2008) and leads to an interactive approach, which creates a more sustainable and
useful project for the stakeholders. The clinical site for this project was a family practice in
Vermont.
Phase 1 of the model was established by discussing needs for improvement in the practice
with the office manager. This DNP student relayed the screening recommendations for IPV,
and the office manager expressed interest in adopting the practice, and therefore improved IPV
screening was identified as a need of the clinic.
Intimate partner violence is only one of two social determinants of health that the
USPSTF has published a recommendation in support of screening for it (Krist et al., 2019). In
order to improve the socioeconomic health of a population, it is important to screen for social
issues such as IPV that negatively impact health outcomes, which established my
“epidemiological diagnosis”, or phase 2 of the PRECEDE/PROCEED model (KU, 2018).
There is evidence that screening and early intervention for IPV can help improve the
negative health consequences of IPV, which is the foundation for phase 3, “behavioral and
environmental diagnosis”, since this evidence-based practice can help reduce the negative
health outcomes that victims of IPV face (KU, 2018; USPSTF, 2018). See Appendix A for the
detailed gap analysis.
Review of the Literature
The databases PubMed and CINHAL were searched using the MeSH terms “intimate
partner violence” OR “IPV” and “primary health care” and “screening”. Filters were applied to
limit the results to the last 5 years and written in English. This left 125 publications in PubMed.
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The same filters were applied in CINHAL, with the addition of including only results that were
peer-reviewed, and published in academic journals, which resulted in 112 results.
All identified sources were reviewed and considered for inclusion if they were an original
research study that took place in the United States, or a systematic review, and pertained to
screening for IPV (tools, rates, barriers, and/or facilitators). Studies were excluded if they
included only pregnant women, or only men, since these are specific populations that are not
easily generalizable. Other issues of IPV, such as negative health outcomes, healthcare
utilization, IPV perpetration, or prevalence of IPV were also excluded since the problem is
focused on improving screening and intervention. Duplicates were removed from the search and
the final study count was 13. Each selected study was reviewed, and information was extracted
regarding the participants, study purpose, research design, findings, and limitations.
Participants, Purposes, and Designs
Of the 13 studies reviewed, participants in seven studies were from a healthcare facility,
including three studies focused on healthcare providers such as physicians, physician assistants,
nurses, and nurse practitioners (Bender, 2016; Meredith et al., 2017; Tavrow et al., 2017). Three
studies included healthcare providers as well as office managers, or other clinic personnel
(Alvarez et al., 2018; Iverson et al., 2019; Williams et al, 2016). The final study was a mixed
methods design including healthcare providers and clinic personnel, as well as chart reviews
(Clark et al., 2020).
There were several different types of study designs used. Five studies were crosssectional, three studies were qualitative, two studies were retrospective chart reviews, two
studies were systematic reviews, and one study used a mixed method design. All of these studies
had the aim of determining current screening practices, with additional information also being
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sought out, such as if provider demographics (Tavrow et al., 2017) or beliefs and self-efficacy
predicted screening rates (Meredith et al., 2017), the comprehensiveness of screening programs
(Williams et al., 2016), how providers respond to IPV disclosure and their views on the use of an
online safety app (Alvarez et al., 2018), barriers and opportunities for screening (Iverson et al.,
2019), and the use of the Consolidated Framework for Implementation Research to identify
barriers and opportunities for screening (Bender, 2016; Clark et al., 2020).
Two studies included patients as participants, with one of those studies evaluating the
benefit and safety of women’s participation in an 18-month IPV screening and intervention
program (Hamberger et al., 2020) and the other being a correlational study to determine accuracy
of IPV screening and demographics of women who have experienced IPV (Latta et al., 2016).
One of the retrospective chart reviews was intended to determine if secondary screening was
taking place for patients who previously screened positive (Iverson et al., 2018), and the other
aimed to determine current screening rates and compare screening rates among physicians and
medical assistants (Sharpless et al., 2018). One of the systematic reviews focused on studies on
screening among healthcare providers (Alvarez et al., 2017) and the other reviewed available
IPV screening tools (Arkins et al., 2016).
Screening Rates and Types
Variable IPV screening rates were noted from the literature. Two studies found similar
screening rates; one found that 59.5% of providers had screened patients for IPV once or more
over the last year (Meredith et al., 2017), and another found that 49% performed routine
screening (Bender, 2016). In contrast, the researchers in one study found that all participants
reported some type of IPV screening (Alvarez et al., 2018). However, this study used only 17
healthcare providers and did not use standardized or consistent screening (Alvarez et al., 2018).
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One study found that only 35% of patients had been screened over the last five months (Clark et
al., 2020), and this came from a chart review which provides a more objective finding.
Researchers in another study reported only 14% of participants “always” screened (Tavrow et
al., 2017). One group of researchers found that the screening rate varied from 0-77% among
clinics in the same network with the same policies (Sharpless et al., 2018). Findings from one
systematic review supports these variable rates, as they reported a routine screening rate of 250%, however rates of selective screening (such as when a patient presents with an injury) were
higher at 45-85% (Alvarez et al., 2017).
In one study in which office managers made up the majority of the participants, 78.1%
reported policies and procedures for IPV screening and response exist, and 75.5% of those
participants reported routine screening over the last 6 months (Williams et al., 2016). In contrast,
another study reported that 69% of participants reported no screening protocol in place or no
knowledge of one in place at their facility (Clark et al., 2020). It is important to note that in the
Williams et al (2016) study, the majority of participants were office managers, compared with
the Clark et al (2020) study, in which physicians and nurses were the participants and a lower
rate of knowledge of screening protocols was reported.
Some researchers found that the type of screener influenced the screening rate. For
example, studies found that nurses or medical assistants had higher rates of screening compared
with physicians (Alvarez et al., 2017; Sharpless et al., 2018). Interestingly, one study reported
that osteopathic physicians were more likely than physicians, nurses, or nurse practitioners to
screen for IPV (Bender, 2016). One group of researchers found no difference in screening rates
based on provider type, but they did find that females were more likely than men to screen
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(Tavrow et al., 2017). Contrary to this finding, two studies found male providers to be more
likely than female providers to screen (Bender, 2016; Sharpless et al., 2018).
Screening Tools
In regard to screening tools, the systematic review of screening tools identified three tools
that had been referenced against a standard and had strong psychometric properties (Arkins et al.,
2016). The Women Abuse Screen Tool (WAST) was the most validated tool and had strong
specificity, but there was a range in its sensitivity (Arkins et al., 2016). The Humiliation, Afraid,
Rape, Kick (HARK) tool had the strongest properties, but had been the least tested (Arkins et al.,
2016). The Abuse Assessment Screen (AAS) had strong specificity, but weak sensitivity (Arkins
et al., 2016).
Self-report of IPV was higher (47% of participants) than positive IPV screens from the
Hurt, Insulted, Threatened, or Screamed at (HITS) questionnaire (33%), and the authors
attributed this to the narrow definition of IPV that the HITS questionnaire refers to (Latta et al.,
2016). However, a higher score overall on the Extended-HITS (E-HITS) questionnaire was
found to infer more severe IPV experiences (Iverson et al., 2018).
One systematic review of healthcare providers reported that indirect screening was more
likely to occur than the use of a standardized tool (Alvarez et al., 2017). In another study, only
6.5% of participants who had an identified screening protocol were able to identify a screening
tool used (Williams et al., 2016). In regard to secondary screening following a positive screen,
only three of 11 medical centers had secondary screening and only 56.4% of women who
initially screened positive received a secondary screening at these sites (Iverson et al., 2018).
Factors Associated with Screening
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There seems to be a relationship between a provider’s confidence, knowledge, or selfefficacy in screening and responding to IPV, and their likelihood of screening. Higher levels of
confidence and self-efficacy were associated with higher levels of screening (Alvarez et al.,
2017; Meredith et al., 2017; Tavrow et al., 2017), and in the study with high screening rates,
most providers also felt “fairly well prepared” to screen for IPV (Alvarez et al., 2018). Similarly,
the more training a provider had in IPV, the more likely they were to screen for IPV (Alvarez et
al., 2018; Bender et al., 2016; Iverson et al., 2019), and this was recognized as a facilitator for
implementing IPV into practice in one study (Alvarez et al., 2017).
Barriers to Screening
Six studies addressed barriers to implementing IPV screening and adequate response, and
they all included lack of referral options or patient resources as a barrier to screening (Alvarez et
al., 2017; Alvarez et al., 2018; Bender, 2016; Clark et al., 2020; Iverson et al., 2019; Tavrow et
al., 2017). This was echoed in the study of patients undergoing an IPV survivor program, in
which several women reported wishing that they had been connected with more resources and
supports (Hamberger et al., 2020). Lack of policies or procedures for IPV screening and response
to positive screens were seen as barriers to screening (Alvarez et al., 2017; Iverson et al., 2019).
Lack of IPV screening and intervention policies and procedures also was associated with
providers feeling inadequately prepared to respond to a positive screen (Alvarez et al., 2018),
and negatively influenced screening rates (Bender, 2016; Clark et al., 2020).
An additional barrier identified was the provider’s discomfort when discussing IPV with
patients, or fear of offending the patient (Alvarez et al., 2017; Iverson et al., 2019; Meredith et
al., 2017). Interestingly, the two studies that focused on female patients as participants found that
they appreciated being asked about IPV and having the opportunity to discuss it (Hamberger et
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al., 2020; Latta et al., 2016). Furthermore, lack of time was also identified as a barrier to
screening (Alvarez et al., 2017; Alvarez et al., 2018; Clark et al., 2020; Iverson et al., 2019).
Response to Positive IPV Screen
There are many approaches that can be taken in response to disclosure of IPV and the
literature shows that a variety of methods are used. Unfortunately, some positive IPV screenings
are not addressed at all (Alvarez et al., 2017). The main option discussed for responding to IPV
included referring to social support services (Alvarez et al., 2017; Alvarez et al., 2018; Iverson et
al., 2018; Latta et al., 2016; Tavrow et al., 2017). In one systematic review, authors discussed
other approaches may consist of empathetic listening, only addressing physical injuries, or
recommending that the patient leave the abusive partner (Alvarez et al., 2017).
Evidence Based Practice: Verification of Chosen Option
Screening rates for IPV are variable, but most studies documented a screening rate of less
than 50%, which is suboptimal given IPV screening is recommended for all women of a
childbearing age (USPSTF, 2018). This review supports the need for implementing standardized
IPV screening in healthcare settings.
Theoretical Framework
Lippit’s Seven-Step Change Theory was used as the theoretical framework for
implementing IPV screening into the primary care setting. Lippit’s theory has been used to
implement new policies into practice. It has been compared to the nursing process, which makes
it particularly an appropriate choice for the DNP project (Appendix B). Lippit posits that change
can fail if not carefully planned (Mitchell, 2013), and implementing a new screening and
intervention policy into a busy primary care clinic was a challenge. Phases one through three
require the problem to be identified and an assessment of the motivation and resources for
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change (Mitchell, 2013). Phases four and five determine the change objective and the role of the
change agent (Mitchell, 2013). Phases six and seven maintain the change and end the change
agent’s role (Mitchell, 2013).
In this DNP project, phases one and two were accomplished in the gap analysis. Phase
three identifies the change agent, which is the DNP student collaborating with key members of
the primary care clinic. The motivation for change was identified as commitment to quality
improvement initiatives in the primary care clinic and to provide evidence-based care. The
objective of the change (phase four) was established as the purpose of the project, to increase
IPV screening in the primary care practice. The role of the change agents in the project,
particularly of the DNP student, was communicated to clinicians and staff. Maintaining the
standardized screening at the completion of the DNP project, phases six and seven, was
encouraged through a clinician and staff feedback survey after project implementation.
Goals, Objectives, and Expected Outcomes
The overall purpose/goal of this DNP project was to increase IPV screening in the
primary care setting. Two objectives focused the project and led to measurable outcomes, which
is outlined in Table 1.
Table 1
Goals, objectives, and outcomes
Goal
Objective
-To increase IPV screening in -The DNP student worked
the primary care setting.
with other members of the
primary care clinic to
implement an IPV screening
policy.
-Women ages 18-55
completed the E-HITS
screening during annual
physical exams.

Outcome
-90% of eligible patients
(women ages 18-55 at annual
physical exams) completed
the E-HITS screening.
-80% of clinicians and staff
agreed that the screening was
efficient and that they would
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like to see the practice
continue the screening.

-To equip the primary care
clinic with resources to
provide interventions for
positive screens.

-The DNP student organized
an educational session
regarding IPV prevalence
and resources.
-The DNP student supplied
the exam rooms with
domestic violence hotline
information

-80% of nursing staff
reported that there were not
any barriers to administering
the screening.
-80% of clinicians reported
that they feel very or
extremely confident in
providing resources and
responding to patients who
may disclose IPV.

Methods
To accomplish the purpose of this project, an educational intervention was provided to
clinicians and staff regarding IPV and available resources. A screening and intervention policy
was also implemented. Measured outcomes include clinician and staff self-report of efficiency of
screening and confidence in providing resources to patients. Outcomes also include screening
rates over a 6-week period and documented interventions provided for positive screens. A costbenefit analysis was completed as it described in Appendix D.
Project Site and Population
This project took place at a family practice clinic in Vermont. The clinic is a physician
owned, independent practice with six primary care clinicians and serves patients who live in
several counties in Vermont. The practice is a certified patient centered medical home (PCMH),
which is designated by the National Committee for Quality Assurance (NCQA). The clinicians
serve patients of all ages, providing preventative care through the lifespan, acute care as needs
arise, and management of chronic conditions.
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The project participants were both clinicians and staff, as well as a subset of the patient
population. The staff participants were six primary care clinicians (three family medicine
physicians and three family nurse practitioners) as well as nursing staff members; four registered
nurses (one of which is the nurse manager), and two medical assistants.
The target patients for screening were women between ages 18-55 who attended the
clinic for an annual physical exam. This age range is consistent with previous studies of IPV
screening that have been completed in these age ranges (USPSTF, 2018). Women of all races,
ethnicities, and sexual orientation were included.
Instruments
To measure the outcomes of this DNP Project, the following instruments were used
(Appendix C):
•

A 5 question IPV screening tool with a 5-point Likert scale, known as the E-HITS
tool, was used to detect IPV among women. The questions in the E-HITS covers
physical, verbal, emotional, and sexual violence and has been found to have a
sensitivity of 75% and a specificity of 82% (USPSTF, 2018).

•

A 4-question survey for clinicians and nursing staff members to complete to
evaluate for barriers to screening, confidence in responding to positive screens,
screening efficiency, and desire to continue the screening.

•

Electronic health record (EHR) report to determine a.) number of E-HITS tools
administered per the number of eligible women seen in the clinic between January
31st and March 11th, 2022, b.) demographic data, including age and race, and c.)
number of positive E-HITS screens.
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Data Collection Procedures
The key members of the project team were the DNP student, the nurse manager, the
office manager, and one staff physician, who is also one of the practice owners. The DNP
student led the team in discussing the implementation of the screening into the primary care
clinic’s workflow by identifying and selecting an IPV screening tool and discussing available
resources for patients who are identified as experiencing IPV. Next, the DNP student arranged 2
educational sessions with the local domestic violence organization which focused on education
regarding IPV and intervening when IPV is identified and resources available for patients.
Following the educational sessions, the administration of IPV screening occurred over a
6-week period. The registered nurses (RNs) and medical assistants (MAs) distributed the E-HITS
screening tool to eligible women who came in for an annual physical exam. RNs and MAs were
instructed to ask that patients be seen alone for the visit if they were accompanied by a partner
and advised to not screen the patient if they are not alone for the visit. The patients completed the
screening tool while in the exam room with the RN or MA, and the RN or MA indicated in the
note whether it was a positive or negative screen using an EHR function that is trackable and
reportable. Any positive screen prompted the RN or MA to verbally inform the clinician, so they
were able to discuss the situation with the patient and provide appropriate interventions based on
that discussion. The DNP student was available throughout the intervention timeframe for any
questions.
Following the 6-week screening period, an electronic anonymous survey was
administered to clinicians and nursing staff members via Google Forms to evaluate for perceived
efficiency of screening and confidence in providing IPV resources to patients, as well as to
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evaluate for any identified barriers to screening, and overall desire to continue using the
screening.
The DNP student performed an EHR report to determine the screening rate, which could
be used to determine if there were associations between overall efficiency of screening,
confidence in providing resources, barriers to screening, and rates of screening. The EHR report
was also used to determine the number of positive screens.
Data Analysis
Descriptive statistics (mean, standard deviation, frequency, and percentage) were used to
describe the demographics (age and race) of the patients who were seen in the clinic during this
6- week period, which was gathered during the EHR report. Descriptive statistics (frequency and
percentage) was also used to determine the number of screens that were completed by the entire
eligible population. The clinician and staff survey responses regarding efficiency of screening,
confidence in providing resources, and barriers to screening were also analyzed using descriptive
statistics (frequency and percentage).
Ethical Considerations/Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) Internal Review Board (IRB)
approval was obtained prior to initiating the DNP Project (Appendix F). IPV is a sensitive topic,
and screening for IPV could be upsetting for a patient. Therefore, the screening questions were
prefaced by a paragraph regarding the importance of IPV in health outcomes but how the
screening is optional and may be declined. The benefits of screening include increased detection
of IPV and opportunity to provide interventions and no adverse effects from screening have been
identified (USPSTF, 2018). The risk to patients who participated in this project is no different
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from the risks of patients receiving standard primary care since routine IPV screening is
recommended by many professional organizations (USPSTF, 2018).
All participant’s health information was protected by the Health Insurance Portability and
Accountability Act of 1996 (HIPAA; Modifications to the HIPAA Privacy, Security,
Enforcement, and Breach Notification Rules, 2013). This includes identifiable information such
as name, date of birth, insurance information, as well as diagnoses (including a victim of partner
violence). Additionally, the DNP student and practice staff involved in this project followed the
Standards of Care for screening and intervening for IPV within the primary care setting. No
identifying information was collected on patient or clinician and staff participants. All data
collected was confidential. This was made possible using the secure, password protected EHR to
report on patient demographics and number of screenings completed, as well as the use of
Google Forms for clinicians and staff to anonymously respond to the survey questions.
Results
The educational component of this project took place over a 2-week period for clinicians
and staff of a primary care clinic. This included 3 physicians, 3 nurse practitioners, 4 RNs, and 2
MAs. The screening component of this project took place over a 6-week period and included
female patients ages 18-55 who came into the clinic for an annual physical exam. Following the
6-week screening, the 6 clinicians and 6 nursing staff members completed a feedback survey via
an anonymous Google Form to respond to the efficiency of screening, barriers to screening,
confidence in responding to positive screens, and desire to see the practice continue using the
screening tool.
Table 2 describes the demographics, specifically age range and race, of the total
population of women ages 18-55 who came into the clinic for an annual physical exam from
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1/31/22-3/11/22. Most patients (n=30, 54.5%) seen during this time were in the 40-55 age range.
The mean age of the sample was 40.17 years old (SD 6.36). Almost all patients (n=53, 96.4%)
were white (see Table 2).
Table 2
Patient Characteristics
Demographic

Number

%

18-30

10

18.2

31-40

15

27.3

40-55

30

54.5

Total

55

100

American Indian/Alaska
Native

0

0

Asian

2

3.6

Black or African American

0

0

Hispanic or Latino

0

0

Native Hawaiian/Pacific
Islander

0

0

White

53

96.5

Total

55

100

Age

Race

During this timeframe, 55 eligible patients were seen in the office, and 44 of these
patients completed the screening tool, for a screening rate of 80% (see Table 2). Out of the 44
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screening tools completed, there were 2 positive screens, for a positivity rate of 0.5%. These
results are depicted in Table 4.
Table 3
Number of Eligible Patients Screened
Screening completed

Number

%

Yes

44

80

No

11

20

Total

55

100

Number

%

Positive

2

0.5

Negative

42

95.5

Total

44

100

Table 4
Screening Results
Result

Only three clinicians (n=3, 50%) and four nursing staff members (n=4, 66.67%)
responded to the feedback survey. Clinicians and nursing staff members were asked about the
efficiency of screening and whether they’d like the practice to continue using the screening.
Almost all participants (n=6, 85.71%) strongly agreed that the screening was efficient, and that
time was not a significant barrier to the screening, with one participant (n=1, 14.29%) that
somewhat agreed. Almost all participants (n=6, 85.71%) responded “yes” to wanting to see the
practice continue the screening, with one participant (n=1, 14.29%) reporting they liked the
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screening but would need a system so it is administered consistently. This data is reflected in
Table 5.
Table 5
Clinician and Staff Feedback on Efficiency and Continuing Screening
Survey Question

Number

%

Strongly disagree

0

0

Somewhat disagree

0

0

Neither agree nor disagree

0

0

Somewhat agree

1

14.29

Strongly agree

6

85.71

Total

7

100

Yes

6

85.71

No

0

0

Uncertain at this time

0

0

Other

1

14.29

Screening is efficient

Desire for the practice to
continue the screening

“I like it but would need to
have a system so that it is
delivered consistently”
Total

7

100

Additionally, nursing staff members were asked about specific barriers to administering
the screening, including time, discomfort with administering the screening tool, patient refusal,
and difficulty remembering to administer the screening. Most of the nursing staff (n=3, 75%)
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reported there were no barriers to screening, with one participant (n=1, 25%) reporting it was
difficult to remember to administer the screening tool as a barrier to screening. These results are
reflected in Table 6.
Table 6
Barriers to Screening Identified by Nursing Staff
Barrier Identified

Number

%

Time

0

0

Difficult to remember to
administer screening

1

25

Patient refusals

0

0

Discomfort with
administering screening

0

0

No barriers

3

75

Total

4

100

Clinicians were asked about their overall confidence in providing resources and
responding to someone who discloses IPV, which is reflected in Table 7. Most clinicians felt
very confident (n=2, 66.67%) and 1 clinician (n=1, 33.33%) felt extremely confident in
responding to disclosed IPV and providing resources to patients.
Table 6
Clinician Confidence in Providing Interventions and Resources
Confidence Level

Number

%

Not at all confident

0

0

Somewhat confident

0

0

Moderately confident

0

0
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Very confident

2

66.67

Extremely confident

1

33.33

Total

3

100

Discussion
Result Summary and Interpretation
More than half (54.5%) of patient participants were in the 40-55 age group, which is
consistent with the notion that Vermont has an aging population. However, data from 2019
Vermont Department of Health population studies showed that within the ages that were
included in the DNP study (ages 18-55), women ages 20-24 made up more of the population,
followed by women ages 50-54 (Vermont Department of Health, 2020). This may indicate this
clinic either has less women in the younger age category or patients in this age range may be less
likely to come in for annual physical exams. It could also be because of an overall small sample
size in the project (n=55). Almost all (96.4%) of patients were white, however, this finding is
consistent with the demographics of Vermont with 94.2% of Vermonters identifying as white
(United States Census Bureau, 2021).
The key finding from this study is that 80% of eligible patients were screened for IPV
during the implementation period. This screening rate greatly exceeds the typical rate for IPV
screening in healthcare settings identified in the literature. One study which had a similar method
to this study of determining IPV screening rates by chart review found only 36% of patients were
screened for IPV (Clark et al., 2020).
Another key finding in the feedback survey was the limited number of barriers that were
identified to screening, the desire to continue the screening in practice, the efficiency of
screening, and the clinician confidence in responding to disclosed IPV. These factors likely led
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to the high screening rate. The only barrier identified by a nursing staff member (n=1, 14.29%)
was difficulty remembering to screen. Almost all clinician and staff participants (n=6, 85.71%)
reported they wanted to see the practice continue the screening, which exceeded the 80% goal.
One participant (n=1, 14.29%) reported they like the screening but would need a system so it is
done consistently, which also speaks to the difficulty of remembering to screen.
All clinicians and staff (n=7, 100%) somewhat or strongly agreed the tool was efficient,
which exceeded the goal of 80%. Additionally, all clinicians who responded to the survey (n=3,
100%) reported they felt very or extremely confident in providing adequate resources and
interventions for patients who disclose IPV, which also exceeded the 80% goal. Lack of time and
lack of confidence are common barriers referenced to in the literature and were likely avoided
due to the planning done by the DNP student to ensure that the screening tool selected was quick
and efficient and clinicians and staff were properly educated on IPV and resources available for
patients who disclose IPV. These higher levels of confidence likely led to the relatively high
screening rate achieved of 80%, considering the consistent literature findings that higher levels
of clinician confidence are associated with higher levels of IPV screening (Alvarez et al., 2017).
Although the main outcome was not the positivity rate of the screenings, it seems that a
positivity rate of 0.5% is lower than expected, since 33% of women in the U.S. experience IPV
at some point during their life (USPSTF, 2018). However, this screening tool asks specifically
about the last 12 months, not over the entire lifetime. Also, the positivity rate could be lower than
expected due to a small sample size of only 44 patients screened and because the screening was
only administered to women ages 18-55. Additionally, it can take women up to eight screenings
before they will disclose IPV, so a longer screening period may show a higher positivity rate.
Response to Research Question
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The DNP student sought to determine if clinician and staff education, as well as
implementing a standardized screening tool, increased IPV screening rates in the primary care
clinic to 90%. Prior to this project, screening for IPV in this primary care practice was
inconsistent and unstandardized, which is similar to other healthcare settings per literature
findings. Following the implementation of this project, clinician, and staff education, as well as
the introduction of a standardized screening tool led to an 80% screening rate. Although the goal
screening rate was not met, the intervention was successful in increasing screening and exceeded
literature findings, which was the overarching research question.
Setting Facilitators and Barriers
This family practice clinic provides evidence-based, comprehensive care to their patients
across the lifespan and are a designated PCMH, which requires active involvement in quality
improvement initiatives. Having a team already involved in quality improvement initiatives was
helpful in facilitating the implementation of this project.
There were several barriers identified throughout the project planning and
implementation. There was a long delay in the educational presentation for clinicians and staff,
which was due to staffing shortages within the local domestic violence organization which is
likely attributable to the Covid-19 pandemic. This led to a shorter implementation period, which
may have contributed to a limitation of the study in terms of data collection and analysis. The
only identified barrier of difficulty remembering to administer the screening could be addressed
by implementing chart alerts to notify the nursing staff member of patients who are eligible for
screening and coming in for an appointment that day.
Limitations and Future Recommendations
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Several study limitations have been identified. The 6-week implementation period was
shorter than the desired 3-month implementation period due to educational delays likely related
to the Covid-19 pandemic. This led to a smaller and non-diverse patient sample, which decreases
the generalizability of results. If the implementation period was extended over a longer period,
that would have increased the sample size and potentially the diversity of the sample.
Limitations of the study also include study design. Working within a small primary care
practice with only 6 primary care clinicians and 6 nursing staff members limited the strength of
methods that could be used. For example, no comparison group was able to be used to draw
stronger conclusions regarding the use of education and standardized screening in increasing
rates of IPV screening. A pre-test and post-test confidence survey completed by clinicians may
have been helpful in determining the influence of the educational session on clinician
confidence. Additionally, there was limited feedback and participation in the survey at the end of
the implementation period. The DNP student used Google Forms to have participants
anonymously fill out the survey, however, a different anonymous format, perhaps using a paper
form, or reminding participants in person, may have led to an increased sample size. Having just
half of participants respond, 6 clinicians and nursing staff members rather than 12, limited the
conclusions that were able to be drawn.
Conclusion
IPV is a highly prevalent problem in the U.S. and leads to a variety of negative health
outcomes. There are screening tools available that accurately detect IPV in women of a
reproductive age, and healthcare providers are recommended by a variety of professional
organizations to implement screening into practice. Despite this recommendation, screening in
the healthcare setting remains low for a variety of reasons, including lack of provider training or
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confidence, lack of time, lack of screening policies, and inadequate resources available to
respond to positive screens.
In this project, the DNP student addressed the problem of lack of IPV screening in a
primary care clinic by providing clinician and staff education on IPV and available resources for
patients, as well as implementing a standardized screening tool for women ages 18-55 at annual
physical exams over a 6-week period. Overall, this was an effective strategy to improve IPV
screening in the primary care setting and led to a screening rate of 80%, which greatly exceeds
typical screening rates found in the literature. Clinicians and nursing staff felt the screening tool
was efficient and that time was not a barrier to screening. Clinicians also reported feeling very or
extremely confident in responding to disclosed IPV and only 1 barrier to screening was identified
by a nursing staff member. This positive feedback likely contributed to the high screening rate.
Future efforts to support IPV screening should include workflow practices to remind the
responsible screeners of when the screening is due and to continue efforts to keep clinicians
informed on resources for patients who experience IPV. This two-part intervention was designed
with the recommendations in mind from professional organizations to provide IPV screening in
the healthcare setting, as well as with the literature findings in mind to help reduce the barriers to
screening to provide women with a screening that could lead to life saving interventions.
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Appendix A
Gap Analysis
Best Practice
Solutions

Best Practice
Strategies

IPV screening for
women of a
reproductive age

Implement a verified
tool for IPV
screening for women
of a reproductive age
into a primary care
practice

Differences Between
Clinical Site and
Best Practices
Unstandardized,
general safety
screening is
conducted for most
patients at wellness
visits, but this doesn’t
specifically address
IPV and therefore is
likely ineffective

Barriers/Facilitators
to Best Practices
Barriers:
-Time constraints for
patients to complete
screening
-Lack of
comfort/confidence
among staff for
providing the
screening
-Patients may decline
filling out more
forms
Facilitators:
-Using a brief
screening tool
-Staff education on
IPV and available
resources

Providing appropriate
resources for ongoing
support for positive
IPV screens

Develop a
standardized plan for
intervention for
positive screens

Unstandardized
interventions take
place that are largely
based on each
clinicians’ individual
preference and time

Barriers:
-Clinicians may not
have enough time or
resources to
appropriately respond
to IPV screens
Facilitators:
-Resources provided
from domestic
violence
organization,
including hotline
number, will help to
quickly access
supports needed
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Appendix B
Ronald Lippit’s Seven-Step Change Theory

(Mitchell, 2013)
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Appendix C
Measurement Instruments
•

Clinician and staff survey
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•

Extended Hurt Insult Threaten Scream (E-HITS)

Over the last 12 months, how often did your partner:
1.
2.
3.
4.
5.

Physically hurt you?
Insult your or talk down to you?
Threaten you with harm?
Scream or curse at you?
Force you to have sexual activities?

Each item is answered on a 5-point Likert scale:
•
•
•
•
•

1=never
2=rarely
3=sometimes
4=fairly often
5=frequently

Score range: 5–25. Cutoff for IPV: ≥7
(Iverson et al., 2018)
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Appendix D
Cost-Benefit Analysis
Costs

Benefits

1 hour of paid time for clinicians and staff to
review IPV presentation
2 medical assistants at approximately
$25/hour=$50
4 registered nurses at approximately
$35/hour=$140
3 nurse practitioners at approximately
$55/hour=$165
3 physicians at approximately
$80/hour=$240
Total=$595

Clinicians will likely be able to bill for the
IPV screening and any subsequent
interventions if it includes counseling/safety
planning and this is required to be covered by
commercial insurance companies. Although
the DNP student is not able to quantify this
currently, it is an expected benefit and
expected to offset the costs of training
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Appendix E
Timeframe Table
Task
Educational
presentations
Meeting with
key team
members to
discuss
implementation
of the
screening
policy into the
workflow
Distribute
evaluation
surveys and
analyze data
Implement IPV
screening (EHITS) for
women ages
18-55 age at
annual physical
exams and new
patient visits
and
standardized
interventions
for positive
screens
Gather data
regarding
screening rates
Share
information
with clinicians
and staff and
discuss longterm adoption
of the policy
into practice

November December January
2021
2021
2022
x
x

February
2022

March
2022

April
2022

x

x

x

x

x

x
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